Literature DB >> 18271118

Delayed hypersensitivity to low-molecular-weight heparin (LMWH) in pregnancy.

E Schapkaitz1, B F Jacobson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18271118

Source DB:  PubMed          Journal:  S Afr Med J


× No keyword cloud information.
  4 in total

1.  VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Shannon M Bates; Ian A Greer; Saskia Middeldorp; David L Veenstra; Anne-Marie Prabulos; Per Olav Vandvik
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  A systematic review on the use of new anticoagulants in pregnancy.

Authors:  Ai-Wei Tang; Ian Greer
Journal:  Obstet Med       Date:  2013-05-03

3.  Fondaparinux Pre-, Peri-, and/or Postpartum for the Prophylaxis/Treatment of Venous Thromboembolism (FondaPPP).

Authors:  Carl-Erik Dempfle; Jürgen Koscielny; Edelgard Lindhoff-Last; Birgit Linnemann; Irene Bux-Gewehr; Günther Kappert; Ute Scholz; Stefan Kropff; Sonja Eberle; Peter Bramlage; Andreas Heinken
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

4.  Retrospective Analysis of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Women With Recurrent Spontaneous Abortion.

Authors:  Long Zhao; Shuqin Bi; Jinhua Fu; Lijuan Qi; Lin Li; Yinghui Fu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-14       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.